New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA moves toward easing restrictions on certain peptides BioPharma Dive Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The peptide problem: Hype is outrunning the evidence